Ascendis Pharma As Stock Price Patterns
| ASND Stock | USD 226.10 0.00 0.00% |
Momentum 55
Impartial
Oversold | Overbought |
EPS Estimate Next Quarter 0.1024 | EPS Estimate Current Year (3.33) | EPS Estimate Next Year 4.0421 | Wall Street Target Price 278.0465 | EPS Estimate Current Quarter (0.16) |
Using Ascendis Pharma hype-based prediction, you can estimate the value of Ascendis Pharma AS from the perspective of Ascendis Pharma response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Ascendis Pharma using Ascendis Pharma's stock options and short interest. It helps to benchmark the overall future attitude of investors towards Ascendis using crowd psychology based on the activity and movement of Ascendis Pharma's stock price.
Ascendis Pharma Short Interest
A significant increase or decrease in Ascendis Pharma's short interest from the previous month could be a good indicator of investor sentiment towards Ascendis. Short interest can provide insight into the potential direction of Ascendis Pharma stock and how bullish or bearish investors feel about the market overall.
200 Day MA 190.4289 | Short Percent 0.0621 | Short Ratio 5.04 | Shares Short Prior Month 3.5 M | 50 Day MA 212.1378 |
Ascendis Pharma AS Hype to Price Pattern
Investor biases related to Ascendis Pharma's public news can be used to forecast risks associated with an investment in Ascendis. The trend in average sentiment can be used to explain how an investor holding Ascendis can time the market purely based on public headlines and social activities around Ascendis Pharma AS. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Ascendis Pharma's market sentiment to its price can help taders to make decisions based on the overall investors consensus about Ascendis Pharma.
Ascendis Pharma Implied Volatility | 0.52 |
Ascendis Pharma's implied volatility exposes the market's sentiment of Ascendis Pharma AS stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Ascendis Pharma's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Ascendis Pharma stock will not fluctuate a lot when Ascendis Pharma's options are near their expiration.
The fear of missing out, i.e., FOMO, can cause potential investors in Ascendis Pharma to buy its stock at a price that has no basis in reality. In that case, they are not buying Ascendis because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Ascendis Pharma after-hype prediction price | USD 223.74 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Prediction based on Rule 16 of the current Ascendis contract
Based on the Rule 16, the options market is currently suggesting that Ascendis Pharma AS will have an average daily up or down price movement of about 0.0325% per day over the life of the 2026-04-17 option contract. With Ascendis Pharma trading at USD 226.1, that is roughly USD 0.0735 . If you think that the market is fully incorporating Ascendis Pharma's daily price movement you should consider acquiring Ascendis Pharma AS options at the current volatility level of 0.52%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Check out Ascendis Pharma Basic Forecasting Models to cross-verify your projections. Ascendis Pharma After-Hype Price Density Analysis
As far as predicting the price of Ascendis Pharma at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Ascendis Pharma or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Ascendis Pharma, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Ascendis Pharma Estimiated After-Hype Price Volatility
In the context of predicting Ascendis Pharma's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Ascendis Pharma's historical news coverage. Ascendis Pharma's after-hype downside and upside margins for the prediction period are 220.98 and 226.50, respectively. We have considered Ascendis Pharma's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Ascendis Pharma is very steady at this time. Analysis and calculation of next after-hype price of Ascendis Pharma AS is based on 3 months time horizon.
Ascendis Pharma Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Ascendis Pharma is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Ascendis Pharma backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Ascendis Pharma, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.23 | 2.76 | 2.36 | 0.84 | 10 Events / Month | 7 Events / Month | In about 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
226.10 | 223.74 | 1.04 |
|
Ascendis Pharma Hype Timeline
Ascendis Pharma AS is presently traded for 226.10. The entity has historical hype elasticity of -2.36, and average elasticity to hype of competition of -0.84. Ascendis is estimated to decline in value after the next headline, with the price expected to drop to 223.74. The average volatility of media hype impact on the company price is about 26.93%. The price decrease on the next news is expected to be -1.04%, whereas the daily expected return is presently at 0.23%. The volatility of related hype on Ascendis Pharma is about 75.25%, with the expected price after the next announcement by competition of 225.26. About 99.0% of the company shares are held by institutions such as insurance companies. The company recorded a loss per share of 4.59. Ascendis Pharma AS had not issued any dividends in recent years. Given the investment horizon of 90 days the next estimated press release will be in about 10 days. Check out Ascendis Pharma Basic Forecasting Models to cross-verify your projections.Ascendis Pharma Related Hype Analysis
Having access to credible news sources related to Ascendis Pharma's direct competition is more important than ever and may enhance your ability to predict Ascendis Pharma's future price movements. Getting to know how Ascendis Pharma's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Ascendis Pharma may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| IONS | Ionis Pharmaceuticals | (0.17) | 9 per month | 1.64 | 0.08 | 3.19 | (2.67) | 8.64 | |
| BBIO | BridgeBio Pharma | (1.38) | 11 per month | 1.59 | 0.18 | 4.65 | (2.55) | 23.30 | |
| RVMD | Revolution Medicines | 0.35 | 9 per month | 2.97 | 0.20 | 5.23 | (2.52) | 45.50 | |
| ROIV | Roivant Sciences | 0.22 | 13 per month | 1.52 | 0.12 | 4.37 | (2.84) | 9.44 | |
| SMMT | Summit Therapeutics PLC | 0.04 | 10 per month | 0.00 | (0.09) | 5.41 | (5.75) | 23.61 | |
| GH | Guardant Health | 0.77 | 8 per month | 1.60 | 0.17 | 5.53 | (3.15) | 33.86 | |
| MDGL | Madrigal Pharmaceuticals | (40.93) | 10 per month | 2.05 | 0.07 | 7.29 | (3.26) | 16.78 | |
| EXEL | Exelixis | (1.48) | 11 per month | 1.71 | 0.04 | 4.06 | (2.93) | 11.45 | |
| BMRN | Biomarin Pharmaceutical | (0.41) | 11 per month | 1.70 | 0.02 | 3.20 | (3.05) | 22.06 | |
| MRNA | Moderna | 6.31 | 9 per month | 3.82 | 0.17 | 10.85 | (7.01) | 23.11 |
Ascendis Pharma Additional Predictive Modules
Most predictive techniques to examine Ascendis price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Ascendis using various technical indicators. When you analyze Ascendis charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Ascendis Pharma Predictive Indicators
The successful prediction of Ascendis Pharma stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Ascendis Pharma AS, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Ascendis Pharma based on analysis of Ascendis Pharma hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Ascendis Pharma's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Ascendis Pharma's related companies. | 2023 | 2024 | 2025 | 2026 (projected) | Payables Turnover | 0.47 | 0.46 | 0.41 | 0.22 | Days Of Inventory On Hand | 1.7K | 2.4K | 2.8K | 4.4K |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Complementary Tools for Ascendis Stock analysis
When running Ascendis Pharma's price analysis, check to measure Ascendis Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ascendis Pharma is operating at the current time. Most of Ascendis Pharma's value examination focuses on studying past and present price action to predict the probability of Ascendis Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ascendis Pharma's price. Additionally, you may evaluate how the addition of Ascendis Pharma to your portfolios can decrease your overall portfolio volatility.
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Stocks Directory Find actively traded stocks across global markets | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |